Publications

[changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in spain: results from the fungemyca study].	recent epidemiological surveillance studies have reported an increase in fungaemia caused by non-candida albicans species, as well as a decrease in fluconazole susceptibility.	2011	21376831
prevalence of candida bracarensis and candida nivariensis in a spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia.	two new species related to candida glabrata, i.e., candida nivariensis and candida bracarensis, have been proposed. the occurrence of these species among isolates collected in a spanish mycology reference laboratory in 2008-2009 was reviewed. in addition, strains recovered as part of an active population-based surveillance of candidemia conducted in barcelona between 2002 and 2003 were also analyzed. among 143 clinical isolates received in 2008-2009, three (2%) were identified as c. bracarensis ...	2011	21198347
predictors of candidaemia caused by non-albicans candida species: results of a population-based surveillance in barcelona, spain.	although candida albicans (ca) is the most common cause of candida bloodstream infections (bsis), recent studies have observed an increasing percentage of candidaemias caused by non-albicans candida species (nac). in the present study, we attempted to identify the predictors of candidaemia due to nac compared to ca. we analyzed data from an active population-based surveillance in barcelona (spain) from january 2002 to december 2003. factors associated with nac fungaemia were determined by multiv ...	2010	20219079
epidemiology and predictors of mortality in cases of candida bloodstream infection: results from population-based surveillance, barcelona, spain, from 2002 to 2003.	we conducted population-based surveillance for candida bloodstream infections in spain to determine its incidence, the extent of antifungal resistance, and risk factors for mortality. a case was defined as the first positive blood culture for any candida spp. in a resident of barcelona, from 1 january 2002 to 31 december 2003. we defined early mortality as occurring between days 3 to 7 after candidemia and late mortality as occurring between days 8 to 30. we detected 345 cases of candidemia, for ...	2005	15815004
in vitro susceptibilities of bloodstream isolates of candida species to six antifungal agents: results from a population-based active surveillance programme, barcelona, spain, 2002-2003.	the antifungal drug susceptibilities of 351 isolates of candida species, obtained through active laboratory-based surveillance in the period january 2002-december 2003, were determined (candida albicans 51%, candida parapsilosis 23%, candida tropicalis 10%, candida glabrata 9%, candida krusei 4%).	2004	15618284
[in vitro sensitivity to 5-fluorocytosine and amphotericin b of yeasts of the candida genus isolated in barcelona].	in 200 strains of candida sp, 38.5% were found to have intermediate sensitivity or to be resistant to amphotericin b and/or 5-fluorocytosine by the agar diffusion method. when the minimal inhibitory concentrations of these strains were measured, only 7.8% were resistant to amphotericin b and 2.8% to 5-fluorocytosine. the species with the highest levels of resistance were c. parapsilosis, c. tropicalis and torulopsis glabrata. candida albicans did not show resistance to 5-fluorocytosine.	1990	2098147